S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
NASDAQ:IRIX

IRIDEX - IRIX Stock Forecast, Price & News

$2.41
+0.04 (+1.69%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.36
$2.57
50-Day Range
$2.00
$2.42
52-Week Range
$1.96
$5.40
Volume
61,467 shs
Average Volume
12,883 shs
Market Capitalization
$38.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

IRIDEX MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
24.5% Upside
$3.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.51) to ($0.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.08 out of 5 stars

Computer And Technology Sector

593rd out of 610 stocks

Electromedical Equipment Industry

23rd out of 24 stocks

IRIX stock logo

About IRIDEX (NASDAQ:IRIX) Stock

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Receive IRIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter.

IRIX Stock News Headlines

IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
IRIDEX Third Quarter 2022 Earnings: Beats Expectations
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Recap: Iridex Q2 Earnings
See More Headlines
Receive IRIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter.

IRIX Company Calendar

Last Earnings
11/10/2022
Today
2/05/2023
Next Earnings (Estimated)
3/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:IRIX
Employees
119
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+24.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-5,220,000.00
Pretax Margin
-15.39%

Debt

Sales & Book Value

Annual Sales
$53.90 million
Book Value
$1.47 per share

Miscellaneous

Free Float
15,331,000
Market Cap
$38.54 million
Optionable
Not Optionable
Beta
1.31

Key Executives

  • David I. Bruce
    President, Chief Executive Officer & Director
  • Patrick Mercer
    Chief Operating Officer
  • Fuad Ahmad
    Chief Financial Officer
  • George R. Marcellino
    Vice President-Clinical Affairs
  • Susan Bruce
    Executive Administrator













IRIX Stock - Frequently Asked Questions

Should I buy or sell IRIDEX stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IRIDEX in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" IRIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IRIX, but not buy additional shares or sell existing shares.
View IRIX analyst ratings
or view top-rated stocks.

What is IRIDEX's stock price forecast for 2023?

1 Wall Street research analysts have issued 12-month price targets for IRIDEX's shares. Their IRIX share price forecasts range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next year. This suggests a possible upside of 24.5% from the stock's current price.
View analysts price targets for IRIX
or view top-rated stocks among Wall Street analysts.

How have IRIX shares performed in 2023?

IRIDEX's stock was trading at $2.01 at the start of the year. Since then, IRIX shares have increased by 19.9% and is now trading at $2.41.
View the best growth stocks for 2023 here
.

When is IRIDEX's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our IRIX earnings forecast
.

How were IRIDEX's earnings last quarter?

IRIDEX Co. (NASDAQ:IRIX) announced its earnings results on Thursday, November, 10th. The medical equipment provider reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.04. The medical equipment provider had revenue of $14.64 million for the quarter, compared to analysts' expectations of $13.87 million. IRIDEX had a negative trailing twelve-month return on equity of 43.06% and a negative net margin of 15.50%.

What guidance has IRIDEX issued on next quarter's earnings?

IRIDEX updated its FY 2022 earnings guidance on Sunday, January, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $56.90 million-$57.10 million, compared to the consensus revenue estimate of $57.20 million.

What is Theodore A. Boutacoff's approval rating as IRIDEX's CEO?

7 employees have rated IRIDEX Chief Executive Officer Theodore A. Boutacoff on Glassdoor.com. Theodore A. Boutacoff has an approval rating of 64% among the company's employees.

What other stocks do shareholders of IRIDEX own?
What is IRIDEX's stock symbol?

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

Who are IRIDEX's major shareholders?

IRIDEX's stock is owned by a number of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Nandini Devi and Robert Earle Grove.
View institutional ownership trends
.

How do I buy shares of IRIDEX?

Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRIDEX's stock price today?

One share of IRIX stock can currently be purchased for approximately $2.41.

How much money does IRIDEX make?

IRIDEX (NASDAQ:IRIX) has a market capitalization of $38.53 million and generates $57.03 million in revenue each year. The medical equipment provider earns $-5,220,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

How many employees does IRIDEX have?

The company employs 119 workers across the globe.

How can I contact IRIDEX?

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The official website for the company is www.iridex.com. The medical equipment provider can be reached via phone at (650) 940-4700, via email at investors@iridex.com, or via fax at 650-940-4710.

This page (NASDAQ:IRIX) was last updated on 2/5/2023 by MarketBeat.com Staff